Literature DB >> 10211423

Stenotrophomonas (Xanthomonas) maltophilia infection in necrotizing pancreatitis.

K E Mönkemüller1, D E Morgan, T H Baron.   

Abstract

CONCLUSION: Although the therapy of infected pancreatic collections or organized pancreatic necrosis remains surgical, we have demonstrated that infected organized pancreatic necrosis can be treated endoscopically.
BACKGROUND: Stenotrophomonas (Xanthomonas) maltophilia has been increasingly recognized as a nosocomial pathogen associated with meningitis, pneumonia, conjunctivitis, soft tissue infections, endocarditis, and urinary tract infections. This organism is consistently resistant to imipenem, a drug commonly employed in patients with necrotizing pancreatitis to prevent local and systemic infections. METHODS AND
RESULTS: We report the first case of infected pancreatic necrosis by S. (X.) maltophilia. Our patient was treated successfully with endoscopic drainage of the pancreatic fluid collection and appropriate antibiogram-based antibiotic therapy. Endoscopic drainage has emerged as one of the treatment modalities for pancreatic fluid collections.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10211423     DOI: 10.1385/IJGC:25:1:59

Source DB:  PubMed          Journal:  Int J Pancreatol        ISSN: 0169-4197


  22 in total

1.  Transmural drainage of pancreatic fluid collections without electrocautery using the Seldinger technique.

Authors:  K E Mönkemüller; T H Baron; D E Morgan
Journal:  Gastrointest Endosc       Date:  1998-08       Impact factor: 9.427

2.  Comparison of treatment with imipenem vs. ceftazidime as a predisposing factor for nosocomial acquisition of Stenotrophomonas maltophilia: a historical cohort study.

Authors:  Y Carmeli; M H Samore
Journal:  Clin Infect Dis       Date:  1997-06       Impact factor: 9.079

3.  Risk factors associated with isolation of Stenotrophomonas (Xanthomonas) maltophilia in clinical specimens.

Authors:  C J VanCouwenberghe; T B Farver; S H Cohen
Journal:  Infect Control Hosp Epidemiol       Date:  1997-05       Impact factor: 3.254

4.  Xanthomonas maltophilia peritonitis in uremic patients receiving continuous ambulatory peritoneal dialysis.

Authors:  C C Szeto; P K Li; C B Leung; A W Yu; S F Lui; K N Lai
Journal:  Am J Kidney Dis       Date:  1997-01       Impact factor: 8.860

Review 5.  Stenotrophomonas (Xanthomonas) maltophilia: a multidrug-resistant nosocomial pathogen.

Authors:  S R Penzak; B J Abate
Journal:  Pharmacotherapy       Date:  1997 Mar-Apr       Impact factor: 4.705

Review 6.  Endocarditis caused by Stenotrophomonas maltophilia: case report and review.

Authors:  F Gutiérrez Rodero; M M Masiá; J Cortés; V Ortiz de la Tabla; V Mainar; A Vilar
Journal:  Clin Infect Dis       Date:  1996-12       Impact factor: 9.079

Review 7.  Stenotrophomonas maltophilia: an unusual cause of biliary sepsis.

Authors:  K A Papadakis; S E Vartivarian; M E Vassilaki; E J Anaissie
Journal:  Clin Infect Dis       Date:  1995-10       Impact factor: 9.079

8.  Acute pancreatitis: value of CT in establishing prognosis.

Authors:  E J Balthazar; D L Robinson; A J Megibow; J H Ranson
Journal:  Radiology       Date:  1990-02       Impact factor: 11.105

9.  Mucocutaneous and soft tissue infections caused by Xanthomonas maltophilia. A new spectrum.

Authors:  S E Vartivarian; K A Papadakis; J A Palacios; J T Manning; E J Anaissie
Journal:  Ann Intern Med       Date:  1994-12-15       Impact factor: 25.391

10.  Endoscopic therapy for organized pancreatic necrosis.

Authors:  T H Baron; W G Thaggard; D E Morgan; R J Stanley
Journal:  Gastroenterology       Date:  1996-09       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.